Meyer Raanan, Schneyer Rebecca J, Hamilton Kacey M, Levin Gabriel, Truong Mireille D, Siedhoff Matthew T, Wright Kelly N
Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California (Drs. Meyer, Schneyer, Hamilton, Truong, Siedhoff, and Wright); The Dr. Pinchas Bornstein Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel (Dr. Meyer).
Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California (Drs. Meyer, Schneyer, Hamilton, Truong, Siedhoff, and Wright).
J Minim Invasive Gynecol. 2025 Feb;32(2):143-150. doi: 10.1016/j.jmig.2024.09.012. Epub 2024 Sep 19.
To compare surgical outcomes among patients undergoing minimally invasive hysterectomy (MIH), laparoscopic or robotic, with minimally invasive gynecologic surgery (MIGS) subspecialists, gynecologic oncologists (GOs), or general obstetrician/gynecologists (OB/GYNs).
Retrospective cohort study.
Quaternary care academic hospital.
Patients undergoing MIH for benign indications from March 2015 to March 2020 were included.
MIH.
The primary outcome was the odds of a composite of any intra- or postoperative complications within 30 days of surgery by surgeons' group. A total of 728 MIHs were performed during the study period and constituted the cohort, of which 368 (50.5%) were performed by MIGSs, 144 (19.8%) by GOs, and 216 (29.7%) by OB/GYNs. Intra- and postoperative complications occurred in 11.7% of the MIGS group, 22.9% of the GO group (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.36-3.71), and 25.9% of the OB/GYN group (OR, 2.65; 95% CI, 1.70-4.12). Major intra- or postoperative complications were associated with surgeons' groups (OR, 7.02; 95% CI, 2.67-18.47, and OR, 6.84; 95% CI, 2.73-17.16 for GO and OB/GYN compared with MIGS, respectively). Intraoperative complication rates were significantly lower for MIGS surgeons (1.4%) than for GOs (9.0%; OR, 7.21; 95% CI, 2.52-20.60) and OB/GYNs (9.7%; OR, 7.82; 95% CI, 2.90-21.06). There was a higher odd of postoperative complications for OB/GYNs than MIGS (18.5% vs 10.9%; OR, 1.86; 95% CI, 1.16-3.00). Rates of conversion to laparotomy were lowest among MIGS surgeons (0.3%) compared with GOs (7.6%) and OB/GYNs (7.9%). Estimated blood loss 90th percentile or higher and surgery time 90th percentile or higher were more common for OB/GYNs than MIGS surgeons (OR, 2.12; 95% CI, 1.07-4.22; OR, 2.48; 95% CI, 1.49-4.12, respectively).
Fellowship-trained MIGS subspecialists had improved surgical outcomes for benign MIH compared with GOs and OB/GYNs, with lower rates of perioperative complications and fewer conversions to laparotomy.
比较接受微创子宫切除术(MIH,包括腹腔镜或机器人手术)的患者,由微创妇科手术(MIGS)亚专科医生、妇科肿瘤学家(GOs)或普通妇产科医生(OB/GYNs)实施手术的效果。
回顾性队列研究。
四级医疗学术医院。
纳入2015年3月至2020年3月因良性指征接受MIH的患者。
MIH。
主要结局是按外科医生分组,患者在术后30天内发生任何术中或术后并发症的综合比值比。研究期间共进行了728例MIH手术,构成该队列,其中368例(50.5%)由MIGS医生实施,144例(19.8%)由GOs医生实施,216例(29.7%)由OB/GYNs医生实施。MIGS组术中及术后并发症发生率为11.7%,GOs组为22.9%(比值比[OR]为2.25;95%置信区间[CI]为1.36 - 3.71),OB/GYNs组为25.9%(OR为2.65;95%CI为1.70 - 4.12)。主要术中或术后并发症与外科医生分组有关(与MIGS相比,GOs组的OR为7.02;95%CI为2.67 - 18.47;OB/GYNs组的OR为6.84;95%CI为2.73 - 17.16)。MIGS外科医生的术中并发症发生率(1.4%)显著低于GOs医生(9.0%;OR为7.21;95%CI为2.52 - 20.60)和OB/GYNs医生(9.7%;OR为7.82;95%CI为2.90 - 21.06)。OB/GYNs医生术后并发症的比值比高于MIGS医生(18.5%对10.9%;OR为1.86;95%CI为1.16 - 3.00)。与GOs医生(7.6%)和OB/GYNs医生(7.9%)相比,MIGS外科医生中转开腹率最低(0.3%)。OB/GYNs医生估计失血量处于第90百分位数及以上和手术时间处于第90百分位数及以上的情况比MIGS外科医生更常见(OR分别为2.12;95%CI为1.07 - 4.22;OR为2.48;95%CI为1.49 - 4.12)。
接受过 fellowship 培训的MIGS亚专科医生在良性MIH手术方面,与GOs医生和OB/GYNs医生相比,手术效果更佳,围手术期并发症发生率更低,中转开腹情况更少。